Valitor
Michael Ostrach is an experienced executive who currently holds positions as the Interim President at a Stealth Biotech start-up and the Interim Chief Executive Officer at Valitor. In the past, Michael has served in various leadership roles including Acting COO at Prolynx, Chief Business Officer at Dynavax Technologies, and President at Kosan Biosciences. Ostrach holds a JD degree from Stanford Law School and a BA from Brown University.
This person is not in any teams
This person is not in any offices
Valitor
Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..